SignificanceThe shortwave infrared (SWIR, ∼900 to 2000 nm) holds promise for label-free measurements of water and lipid content in thick tissue, owed to the chromophore-specific absorption features and low scattering in this range. In vivo water and lipid estimations have potential applications including the monitoring of hydration, volume status, edema, body composition, weight loss, and cancer. To the best of our knowledge, there are currently no point-of-care or wearable devices available that exploit the SWIR wavelength range, limiting clinical and at-home translation of this technology.AimTo design and fabricate a diffuse optical wearable SWIR probe for water and lipid quantification in tissue.ApproachSimulations were first performed to confirm the theoretical advantage of SWIR wavelengths over near infrared (NIR). The probe was then fabricated, consisting of light emitting diodes at three wavelengths (980, 1200, 1300 nm) and four source-detector (S-D) separations (7, 10, 13, 16 mm). In vitro validation was then performed on emulsion phantoms containing varying concentrations of water, lipid, and deuterium oxide (D2O). A deep neural network was developed as the inverse model for quantity estimation.ResultsSimulations indicated that SWIR wavelengths could reduce theoretical water and lipid extraction errors from ∼6 % to ∼1 % when compared to NIR wavelengths. The SWIR probe had good signal-to-noise ratio (>32 dB up to 10 mm S-D) and low drift (<1.1 % up to 10 mm S-D). Quantification error in emulsion phantoms was 2.1 ± 1.1 % for water and −1.2 ± 1.5 % for lipid. Water estimation during a D2O dilution experiment had an error of 3.1 ± 3.7 % .ConclusionsThis diffuse optical SWIR probe was able to quantify water and lipid contents in vitro with good accuracy, opening the door to human investigations.
Diffuse optical spectroscopy (DOS) is a technique that leverages light propagation in highly scattering media to measure tissue optical properties. This technique is also commonly referred to as near-infrared spectroscopy (NIRS) when utilizing wavelengths in the near-infrared (NIR) region ( to 1000 nm). DOS and NIRS have been widely applied in medical diagnostics in applications ranging from cancer to neuroscience.1 Three types of NIRS modalities are commonly used in biological measurements: continuous wave (CW), frequency domain (FD), and time domain (TD).1–3 Among these techniques, only FD-NIRS and TD-NIRS allow for the decoupling of absolute absorption () and reduced scattering () from the measured optical signal.4 Specifically, for FD-NIRS, the absolute measurements of both and can be achieved using calibrated amplitude and phase information of the detected light after traveling through tissue.1,5 One of the limitations of FD-NIRS is the added instrumental complexity compared with CW-NIRS, which typically restricts absolute measurements of optical properties to only a few wavelengths simultaneously. To address this, hybrid FD + CW systems have been developed to acquire absolute broadband and spectra.5–7 Though prior NIRS techniques have focused on quantifying oxygenated and deoxygenated hemoglobin ( and Hb, respectively),1,2 there has been a growing interest over the last decade in using diffuse optical techniques to measure tissue concentrations of water and lipids.8–11
SignificancePoor fluid management during hemodialysis in patients with end-stage kidney disease contributes to adverse clinical outcomes. Current tools for assessing volume status are limited, and there is a need for objective measurement techniques.AimWe aim to evaluate the ability of a hybrid frequency-domain (FD) and broadband continuous-wave near-infrared spectroscopy (FD-Bb-NIRS) system to monitor tissue changes during hemodialysis and identify markers associated with intradialytic adverse events.ApproachA custom-built FD-Bb-NIRS system was used to acquire continuous optical measurements. The system utilized FD laser diodes (730, 785, 852, and 940 nm) and broadband illumination (700 to 1000 nm). These measurements were integrated using model-based analysis to provide broadband absorption and reduced scattering spectra. Beer’s law was used to extract tissue chromophore concentrations.ResultsAcross 27 subjects, the water ratio ([water]/([water] + [lipid])) showed significant differences between subjects with and without intradialytic adverse events (p=0.0331), with a decrease observed in patients without adverse events. In addition, tissue scattering parameters contributed to the multivariate classification of adverse event discrimination.ConclusionsThe FD-Bb-NIRS device successfully measured changes in tissue fluid dynamics during hemodialysis. Longitudinal water ratio measurements show promise as optical markers for identifying patients at risk of adverse events.